In Vivo 11β-HSD-2 Activity
- 1 December 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 38 (6) , 1330-1336
- https://doi.org/10.1161/hy1101.096112
Abstract
Loss-of-function mutations or inhibition of 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD-2) results in overstimulation of the mineralocorticoid receptor by cortisol and causes salt-sensitive hypertension. Traditionally, 11beta-HSD-2 activity has been assessed by measurement of the urinary cortisol metabolite ratio (tetrahydrocortisol [THF]+5alpha-THF)/tetrahydrocortisone (THE). Recently, the ratio of urinary free glucocorticoids, UFF/UFE, has been suggested to be a more reliable parameter, an aspect that has not been investigated systematically. Steroid metabolites were measured repeatedly by gas chromatography-mass spectrometry in 20 healthy subjects at baseline and after 1 week each of a 30- or 180-mmol/d of sodium diet or 500 mg/d of glycyrrhetinic acid. Intraindividual coefficients of variation from 3 random urine collections for (THF+5alpha-THF)/THE and UFF/UFE ratios were 11+/-9% and 25+/-14% (P<0.001). (THF+5alpha-THF)/THE was more sensitive than UFF/UFE for detection of glycyrrhetinic acid-induced increases higher than the upper 95% confidence interval of the coefficient of variation of the corresponding ratio. Low- or high-salt diet did not alter either ratio. Mean (THF+5alpha-THF)/THE but not UFF/UFE was higher in salt-sensitive than salt-resistant subjects. Absolute glycyrrhetinic acid-related increase in (THF+5alpha-THF)/THE but not UFF/UFE was higher in salt-sensitive than salt-resistant subjects and correlated with changes in mean BP. Intraindividual variability of (THF+5alpha-THF)/THE is lower than that of UFF/UFE. The UFF/UFE ratio does not appear to be more sensitive than (THF+5alpha-THF)/THE for detection of decreased 11beta-HSD-2 activity. The (THF+5alpha-THF)/THE ratio better discriminates between salt-sensitive and salt-resistant subjects. Together with BP responses to glycyrrhetinic acid, these findings support a pivotal role of 11beta-HSD-2 in salt sensitivity.Keywords
This publication has 22 references indexed in Scilit:
- Structural analysis of the 11β-hydroxysteroid dehydrogenase type 2 gene in end-stage renal diseaseKidney International, 2000
- The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertensionJournal Of Hypertension, 2000
- Regulation Of 11β-Hydroxysteroid Dehydrogenase Enzymes By Dietary Sodium In The RatEndocrine Research, 2000
- Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in manClinical Endocrinology, 1996
- Point mutations abolish 11β-hydroxysteroid dehydrogenase type II activity in three families with the congenital syndrome of apparent mineralocorticoid excessMolecular and Cellular Endocrinology, 1996
- Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenaseNature Genetics, 1995
- Gastrointestinal Absorption Characteristics of Glycyrrhizin from Glycyrrhiza Extract.Biological & Pharmaceutical Bulletin, 1995
- Protein kinase C and insulin receptor β-subunit serine phosphorylation in cultured foetal rat hepatocytesMolecular and Cellular Endocrinology, 1994
- Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertensionClinical Endocrinology, 1993
- Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension researchThe Journal of Steroid Biochemistry and Molecular Biology, 1993